van Dijk Marcus Antonius 4
4 · MiNK Therapeutics, Inc. · Filed Jan 11, 2023
Insider Transaction Report
Form 4
van Dijk Marcus Antonius
Chief Technology Officer
Transactions
- Award
Stock Option
2023-01-09+15,000→ 15,000 totalExercise: $2.32Exp: 2033-01-09→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Option was granted on January 9, 2023 and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. Option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.